Well beyond tomorrow

At SynDermix, our vision is to deliver breakthrough innovation that addresses patient convenience equally well to efficacy and safety in areas of major unmet medical need

SynDermix is a Swiss developer of innovative health technologies that focuses on the development of effective and safe treatments that meaningfully respect patient convenience and address important unmet medical needs.

About us

Latest events and updates

Collaboration with King’s College London on the Formulation Development of SDX-21 1 July, 2019 in Updates

SynDermix AG is proud to announce its collaboration with King’s College London for the development of its Nitric Oxide technology. (more…)

AGM 2019: Re-election of Chairman and Board of Directors 11 June, 2019 in Updates

Shareholders approve all proposals put forward by the Board of Directors and re-elect the Chairman and Directors to the board of SynDermix.

Swiss Biotech Day, Basel 7 May, 2019 in Events

SynDermix attends Swiss Biotech Day 2019, the annual get-together of the Swiss biopharmaceutical industry. (more…)

Our platform technologies